Padua Prediction Score for Risk of VTE
Determines anticoagulation need in hospitalized patients by risk of VTE.
287 entries · Page 7 of 10
Determines anticoagulation need in hospitalized patients by risk of VTE.
Assesses pain in patients with dementia.
Predicts postoperative pancreatic fistula, based on intraoperative findings, after pancreatic resection.
Calculates fluid requirements for burn patients in a 24-hour period.
Quantifies severity of rheumatoid arthritis (RA) using patient-reported symptoms.
Quantifies severity of rheumatoid arthritis (RA) and has fewer questions than PAS.
Predicts risk of urinary tract infection, bacteremia, or bacterial meningitis in febrile infants age 29-60 days old.
Quantifies appendicitis risk in pediatric patients with abdominal pain, possibly better than the Pediatric Appendicitis Score .
Assesses impaired consciousness and coma in pediatric patients.
Stratifies severity of illness and predicts mortality in pediatric patients after trauma.
Determines severity of ulcerative colitis (UC) in pediatric patients.
Predicts 6-month risk of amputation and mortality in diabetic foot ulcers.
Rules out PE if no criteria are present and pre-test probability is ≤15%.
Corrects serum phenytoin level for renal failure and/or hypoalbuminemia.
Predicts ICU mortality in patients with community-acquired pneumonia.
Predicts ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura (TTP) with high discrimination.
Predicts mortality for cancer patients with PE.
Estimates morbidity and mortality for general surgery patients.
Predicts risk of severe alcohol withdrawal in hospitalized patients.
Predicts survival after ECMO for acute respiratory distress syndrome.
Predicts risk of perioperative mortality in general surgery patients.
Predicts overall survival in chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
Predicts cancer mortality from serum biomarkers.
Predicts 3-month mortality in patients with malignant pleural effusion.
Estimates mortality for adult patients with community-acquired pneumonia.
Predicts 30-day outcome of patients with pulmonary embolism.
Identifies high-risk patients for in-hospital mortality with suspected infection outside the ICU.
Differentiates cholestatic from hepatocellular liver injury, recommended by ACG guidelines .
Calculates biologically effective dose (BED) and equivalent dose (EQD2) for cancer radiotherapy.
No entries match your filter.